Alps Advisors Inc Biotechnology

Alps Advisors Inc

$17.2 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
HRMY Harmony Biosciences Holdings, Inc.	$2.1B	$347,000 0.0% of portfolio	10,473	Q1 2025 Added 13.3%
KRYS Krystal Biotech, Inc.	$3.49B	$346,000 0.0% of portfolio	1,920	Q1 2025 New
UTHR United Therapeutics Corp	$12.8B	$344,000 0.0% of portfolio	1,116	Q1 2025 Added 10.39%
MDXG Mimedx Group, Inc.	$720M	$339,000 0.0% of portfolio	44,690	Q1 2025 New
REGN Regeneron Pharmaceuticals, Inc.	$56.1B	$336,000 0.0% of portfolio	530	Q1 2025 Added 70.97%
TBPH Theravance Biopharma, Inc.	$719M	$322,000 0.0% of portfolio	36,079	Q1 2025 Reduced 9.26%
SVRA Savara Inc	$285M	$320,000 0.0% of portfolio	115,752	Q1 2025 Reduced 16.59%
CAPR Capricor Therapeutics, Inc.	$273M	$315,000 0.0% of portfolio	33,230	Q1 2025 Reduced 9.63%
AUTL Autolus Therapeutics PLC	$218M	$309,000 0.0% of portfolio	199,709	Q1 2025 Reduced 7.19%
KROS Keros Therapeutics, Inc.	$389M	$303,000 0.0% of portfolio	29,736	Q1 2025 Reduced 9.22%
CELC Celcuity Inc.	$196M	$291,000 0.0% of portfolio	28,798	Q1 2025 Reduced 4.1%
ERAS Erasca, Inc.	$192M	$288,000 0.0% of portfolio	210,283	Q1 2025 Reduced 8.02%
STOK Stoke Therapeutics, Inc.	$429M	$265,000 0.0% of portfolio	39,890	Q1 2025 Reduced 6.86%
ALDX Aldeyra Therapeutics, Inc.	$150M	$251,000 0.0% of portfolio	43,803	Q1 2025 Reduced 9.04%
AMLX Amylyx Pharmaceuticals, Inc.	$300M	$239,000 0.0% of portfolio	67,597	Q1 2025 Added 21.95%
ATXS Astria Therapeutics, Inc.	$75.1M	$231,000 0.0% of portfolio	43,444	Q1 2025 Reduced 4.79%
AURA Aura Biosciences, Inc.	$179M	$217,000 0.0% of portfolio	37,156	Q1 2025 Reduced 8.01%
ARCT Arcturus Therapeutics Holdings Inc.	$317M	$211,000 0.0% of portfolio	19,949	Q1 2025 Reduced 8.91%
VNDA Vanda Pharmaceuticals Inc.	$248M	$192,000 0.0% of portfolio	41,993	Q1 2025 Reduced 10.94%
OLMA Olema Pharmaceuticals, Inc.	$179M	$189,000 0.0% of portfolio	50,484	Q1 2025 Added 8.95%
ITOS I Teos Therapeutics, Inc.	$362M	$171,000 0.0% of portfolio	28,646	Q1 2025 Reduced 3.03%
ANNX Annexon, Inc.	$130M	$159,000 0.0% of portfolio	82,626	Q1 2025 Reduced 4.14%
ELDN Eledon Pharmaceuticals, Inc.	$43.6M	$150,000 0.0% of portfolio	44,436	Q1 2025 Reduced 8.02%
YMAB Y M Abs Therapeutics, Inc.	$223M	$147,000 0.0% of portfolio	33,309	Q1 2025 Reduced 8.02%
RZLT Rezolute, Inc.	$172M	$124,000 0.0% of portfolio	43,086	Q1 2025 Reduced 8.03%
FDMT 4 D Molecular Therapeutics, Inc.	$135M	$105,000 0.0% of portfolio	32,811	Q1 2025 Reduced 12.22%
LRMR Larimar Therapeutics, Inc.	$104M	$102,000 0.0% of portfolio	47,460	Q1 2025 Reduced 8.01%
ALEC Alector, Inc.	$116M	$92,000 0.0% of portfolio	74,933	Q1 2025 Reduced 5.29%
ENTA Enanta Pharmaceuticals Inc	$149M	$89,000 0.0% of portfolio	16,257	Q1 2025 Reduced 5.14%
ZNTL Zentalis Pharmaceuticals, Inc.	$83.8M	$87,000 0.0% of portfolio	55,033	Q1 2025 Reduced 4.44%
PROK Prokidney Corp Ord Shs Cl A(Cy	$44.3M	$83,000 0.0% of portfolio	95,182	Q1 2025 Reduced 8.02%
PLRX Pliant Therapeutics, Inc.	$79.8M	$61,000 0.0% of portfolio	45,261	Q1 2025 Reduced 8.02%
MGNX Macrogenics Inc	$107M	$61,000 0.0% of portfolio	48,646	Q1 2025 Reduced 4.15%
STRO Sutro Biopharma, Inc.	$44.3M	$39,000 0.0% of portfolio	61,267	Q1 2025 Reduced 8.07%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.